Scottsdale, AZ – November 18, 2019 – RenovaCare, Inc. (Symbol: RCAR; www.renovacareinc.com), developer of patented technologies for spraying self-donated stem cells for the regeneration of tissues and organs, today announced the appointment of Alan L. Rubino as President and Chief Executive Officer. Mr. Rubino will lead the Company through its next stages of clinical and corporate development and financial growth.
Scottsdale, AZ – September 24th, 2019 – RenovaCare, Inc. (Symbol: RCAR; www.renovacareinc.com), developer of patented technologies for spraying self-donated stem cells for the regeneration of tissues and organs, is pleased to announce the appointment of Dr. Frank Gerberick to its Board of Advisors to help advance the Company’s SkinGun™ cell spray technology for the regeneration of human skin.
Scottsdale, AZ – August 20th, 2019 – RenovaCare, Inc. (Symbol: RCAR; www.renovacareinc.com), developer of patented technologies for spraying self-donated stem cells for the regeneration of tissues and organs, is pleased to announce the appointment of its Vice President of Scientific Affairs, Dr. Robin A. Robinson, a respected authority on the development of breakthrough biomedical technologies.
Scottsdale, AZ – August 14, 2019 – RenovaCare, Inc., (Symbol: RCAR; www.renovacareinc.com), developer of the SkinGun™ for spraying a patient’s own stem cells onto burns and wounds for accelerated self-healing, announced the issuance of a new patent (U.S. Patent Number 10,376,658) allowing the Company’s novel medical device to now spray all varieties of tissues and cells, thus opening the door for its potential application in the regeneration of tissues and organs, beyond skin.
Scottsdale, AZ – July 11, 2019 – RenovaCare, Inc., (Symbol: RCAR; www.renovacareinc.com), developer of the SkinGun™ for spraying a patient’s own stem cells onto burns and wounds for accelerated self-healing, is pleased to announce the appointment of Dr. Ben Walthall to the Company’s Advisory Board.
Scottsdale, AZ– June 27, 2019 – RenovaCare, Inc., RenovaCare, Inc., (OTC: RCAR), developer of the SkinGun™ and other patented technologies for spraying a patient’s own stem cells onto burns and wounds for accelerated self-healing, is pleased to announce the appointment of Dr. Rodney L. Sparks as Vice President of Intellectual Property.
Scottsdale, AZ– June 6th, 2019 – RenovaCare, Inc., (Symbol: RCAR; www.renovacareinc.com) developer of patented technologies for spraying a patient’s own stem cells onto burns and wounds for accelerated self-healing, is pleased to announce the appointment of Dr. Roger Esteban-Vives as Vice President of Research and Product Development.
Scottsdale, AZ– November 29th, 2018 – RenovaCare, Inc., (Symbol: RCAR; www.renovacareinc.com) today announced an equity financing for $15.5 million from Kalen Capital Corporation, the family office of Mr. Harmel S. Rayat, majority shareholder and Chairman of RenovaCare. This increases his family office’s total equity investment in RenovaCare since 2013 to over $20 million.
Scottsdale, AZ – October 26, 2018 – RenovaCare, Inc., (OTC: RCAR),developer of patented technologies* for isolating and spraying a patient’s own stem cells onto burns and wounds for rapid self-healing, today announced the appointment of Mr. Steve Yan-Klassen, CPA, CMA, as its Chief Financial Officer.
RenovaCare, Inc., (RCAR), announces the appointment of Mr. Harmel S. Rayat, longtime majority stockholder, as Chairman of its Board of Directors.